Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks under $50 to buy right now. On May 6, Recursion reported significant progress across its AI-driven clinical pipeline for Q1 ...
UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% and speeding inference 2.4x.
Compare top AI app builders for prototyping, mobile apps, internal tools, backend depth, security, pricing, and code ...
The real headline is what ZAYA1-8B was trained on: a full stack of AMD Instinct MI300 graphics processing units (GPUs), the rival to Nvidia GPUs.
Three humans, eight AI team members, one product. The multi-agent collaboration pattern Stark Insider readers have been ...
Google reported the first confirmed AI-assisted zero-day exploit, raising new concerns about logic flaws, supply chain risk, and containment.
XDA Developers on MSN
Most people never check this one router setting, and it's why their internet feels slow
Hiding in plain sight.
New Mercer research spoke to about 12,000 executives and found that they expect some serious organisational design changes ...
As competitor search engines surge on Google's AI obsession, Microsoft has a very, very rare opportunity to exploit the ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results